Companies formed

Since 1997, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and has spun out a new company every two months on average.

Over £266 million in external investment has been raised by Oxford University Innovation spinouts since 2000, and five are currently listed on London’s AIM market.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

2011

Advanced materials and technologies in safe, lightweight, high performance hydrogen storage technology.

Incorporated in January 2011

Origin: Oxford University, Science and Technology Facilities Council

2010

A biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases.

Incorporated in November 2010

Origin: Oxford University, Department of Surgical Sciences

Kepler Energy Limited develops a second-generation tidal turbine, which has the potential to harness tidal energy more efficiently and cheaply, using a device which is simpler, more robust and more scalable than current designs.

Incorporated in October 2010

Origin: Oxford University, Department of Engineering Science

Oxford Electromagnetic Solutions - smart asset management through underground network visibility.

Incorporated in June 2010

Origin: Oxford University, Department of Engineering Science

Oxidative Enzymes for the Pulp and Paper Industry.

Incorporated in February 2010

Origin: Oxford University, Department of Chemistry

2009

YASA Motors manufactures a highly differentiated advanced axial flux motor and generator based on its proprietary Yokeless And Segmented Armature (YASA™) technology.

Incorporated in August 2009

Origin: Oxford University, Department of Engineering Science

Using leading edge human biomimetic platforms to test and develop therapeutics for serious human diseases.

Incorporated in July 2009

Origin: Oxford University, Institute of Biomedical Engineering

Incorporated in March 2009

Origin: Oxford University, Department of Mathematics/Oxford e-Research Centre

2008

The OrganOx metra is the first and only fully automated normothermic liver perfusion device for improved organ preservation. The OrganOx pipeline products will extend the use of their core technology to the preservation of other organs.

Incorporated in November 2008

Origin: Oxford University, Institute of Biomedical Engineering/Nuffield Department of Surgical Sciences

Navetas is a UK based technology company delivering cloud-based energy monitoring and smart data analytics for the connected home.

Incorporated in November 2008

Origin: Oxford University, Department of Engineering Science

New tuberculosis vaccine – MVA85A.

Incorporated in July 2008

SemmleCode is a line of products aimed to help developer teams improve their software quality.

Incorporated in March 2008

Origin: Oxford University, Department of Computer Science

2007

Crysalin develop a protein lattice technology that is founded on a novel form of highly ordered materials, crysalins, that are produced through modification of naturally occurring protein building blocks.

Incorporated in June 2007

Origin: Oxford University, Department of Biochemistry

ClinOx offers clients knowledge and expertise in the development, placement, conduct and analysis of early phase oncology clinical trials, with particular emphasis on pharmacokinetic and mechanistic endpoints.

Incorporated in June 2007

Origin: Oxford University, Nuffield Division of Clinical and Laboratory Sciences

2006

Oxtox develops medical devices for the detection of specific drugs in the human system.

Incorporated in November 2006

Origin: Oxford University, Department of Chemistry

Cytox develops a technology platform for tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias.

Incorporated in October 2006

Origin: Oxford University, Division of Clinical Neurology/Weatherall Institute of Molecular Medicine

Search

Ready to get in touch?

Contact Us
Search
© Oxford University Innovation